Literature DB >> 1658185

Nitric oxide derived from L-arginine impairs cytoplasmic pH regulation by vacuolar-type H+ ATPases in peritoneal macrophages.

C J Swallow1, S Grinstein, R A Sudsbury, O D Rotstein.   

Abstract

The ability of macrophages (Møs) to function within an acidic environment has been shown to depend on cytoplasmic pH (pHi) regulation by vacuolar-type H+ ATPases. Møs metabolize L-arginine via an oxidative pathway that generates nitric oxide, nitrate, and nitrite. Since each of these products could potentially inhibit vacuolar-type H+ ATPases, we investigated the effect of L-arginine metabolism on Mø pHi regulation in thioglycolate-elicited murine peritoneal Møs. H+ ATPase-mediated pHi recovery from an imposed cytoplasmic acid load was measured fluorometrically. When Møs were incubated with L-arginine (0.25-2.0 mM), their rate of pHi recovery declined progressively from 2 to 6 h of incubation. By contrast, the recovery rate of cells incubated in arginine-free medium remained stable over the same period. The impairment of pHi recovery was specific for L-arginine, and was blocked competitively by NG-monomethyl-L-arginine, demonstrating its dependence on L-arginine metabolism. In addition, the inhibition of pHi recovery was enhanced by lipopolysaccharide, an agent known to stimulate L-arginine metabolism by Møs. Scavenging the L-arginine metabolite nitric oxide with either ferrous sulphate or ferrous myoglobin prevented the inhibition of pHi recovery, implying that L-arginine-derived nitric oxide was the species responsible for the inhibition. This concept was supported by the finding of elevated nitrite levels in the supernatant of cells incubated in L-arginine. Furthermore, incubation of Møs with sodium nitroprusside mimicked the L-arginine-dependent inhibition of H+ ATPase activity. Treatment with the cyclic GMP analogue, 8-bromoguanosine 3':5'-cyclic monophosphate, similarly impaired Mø pHi recovery, suggesting that a nitric oxide-stimulated elevation of cyclic GMP may contribute to the L-arginine-dependent inhibition of pHi regulation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1658185      PMCID: PMC2119012          DOI: 10.1084/jem.174.5.1009

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  58 in total

Review 1.  The macrophages: effector cell wound repair.

Authors:  D R Knighton; V D Fiegel
Journal:  Prog Clin Biol Res       Date:  1989

Review 2.  Structure and function of vacuolar class of ATP-driven proton pumps.

Authors:  M Forgac
Journal:  Physiol Rev       Date:  1989-07       Impact factor: 37.312

Review 3.  Physiological role of cGMP and cGMP-dependent protein kinase in the cardiovascular system.

Authors:  U Walter
Journal:  Rev Physiol Biochem Pharmacol       Date:  1989       Impact factor: 5.545

4.  Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells.

Authors:  J C Drapier; J B Hibbs
Journal:  J Immunol       Date:  1988-04-15       Impact factor: 5.422

5.  Macrophage oxidation of L-arginine to nitric oxide, nitrite, and nitrate. Tetrahydrobiopterin is required as a cofactor.

Authors:  M A Tayeh; M A Marletta
Journal:  J Biol Chem       Date:  1989-11-25       Impact factor: 5.157

6.  H+-translocating ATPase in Golgi apparatus. Characterization as vacuolar H+-ATPase and its subunit structures.

Authors:  Y Moriyama; N Nelson
Journal:  J Biol Chem       Date:  1989-11-05       Impact factor: 5.157

7.  Mechanisms of cytoplasmic pH recovery in acid-loaded macrophages.

Authors:  C J Swallow; O D Rotstein; S Grinstein
Journal:  J Surg Res       Date:  1989-06       Impact factor: 2.192

8.  Heterogeneity of cAMP effect on endosomal proton transport.

Authors:  R W Gurich; T D DuBose
Journal:  Am J Physiol       Date:  1989-11

9.  Regulation of macrophage functions by L-arginine.

Authors:  J E Albina; M D Caldwell; W L Henry; C D Mills
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

10.  Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells.

Authors:  D J Stuehr; C F Nathan
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

View more
  6 in total

1.  Analysis of the in vitro effect of exogenous nitric oxide on human lymphocytes.

Authors:  A S Shoker; H Yang; M A Murabit; H Jamil; A al-Ghoul; K Okasha
Journal:  Mol Cell Biochem       Date:  1997-06       Impact factor: 3.396

2.  Surfactant blocks lipopolysaccharide signaling by inhibiting both NFκB and PARP activation in experimental ARDS.

Authors:  Neha Mittal; Sankar Nath Sanyal
Journal:  Mol Cell Biochem       Date:  2011-04-02       Impact factor: 3.396

3.  Nitric oxide increases susceptibility of Toll-like receptor-activated macrophages to spreading Listeria monocytogenes.

Authors:  Caroline Cole; Stacey Thomas; Holly Filak; Peter M Henson; Laurel L Lenz
Journal:  Immunity       Date:  2012-04-26       Impact factor: 31.745

4.  Acyl phosphatase activity of NO-inhibited glyceraldehyde-3-phosphate dehydrogenase (GAPDH): a potential mechanism for uncoupling glycolysis from ATP generation in NO-producing cells.

Authors:  J E Albina; B Mastrofrancesco; J S Reichner
Journal:  Biochem J       Date:  1999-07-01       Impact factor: 3.857

5.  NO3--induced pH changes in mammalian cells. Evidence for an NO3--H+ cotransporter.

Authors:  C W Chow; A Kapus; R Romanek; S Grinstein
Journal:  J Gen Physiol       Date:  1997-08       Impact factor: 4.086

6.  Extracellular Acidity Reprograms Macrophage Metabolism and Innate Responsiveness.

Authors:  Wei Jiang; James Le; Ping-Yuan Wang; Xiaofang Cheng; Margery Smelkinson; Wenyue Dong; Chen Yang; Yiwei Chu; Paul M Hwang; Robert S Munford; Mingfang Lu
Journal:  J Immunol       Date:  2021-06-09       Impact factor: 5.426

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.